Profile data is unavailable for this security.
About the company
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
- Revenue in USD (TTM)315.66m
- Net income in USD-102.45m
- Incorporated2001
- Employees834.00
- LocationInogen Inc859 WARD DRIVEGOLETA 93111United StatesUSA
- Phone+1 (805) 562-0500
- Fax+1 (302) 636-5454
- Websitehttps://www.inogen.com/
More ▼
Mergers & acquisitions
| Acquired company | INGN:NSQ since announced | Transaction value |
|---|---|---|
| Physio-Assist SAS | -37.24% | 50.08m |
Data delayed at least 15 minutes, as of Apr 25 2024 18:47 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuronetics Inc | 71.35m | -30.19m | 112.40m | 203.00 | -- | 3.19 | -- | 1.58 | -1.06 | -1.06 | 2.49 | 1.18 | 0.6132 | 2.09 | 4.86 | 351,468.00 | -25.95 | -28.02 | -33.60 | -34.73 | 75.13 | 75.73 | -42.31 | -51.04 | 4.33 | -5.28 | 0.6342 | -- | 9.42 | 6.22 | 18.76 | -- | 18.57 | -- |
| Akso Health Group - ADR | 2.20m | -17.07m | 112.95m | 12.00 | -- | -- | -- | 51.28 | -0.7466 | -0.2461 | 0.0963 | -- | 0.1166 | 1.91 | 0.3202 | 183,560.00 | -89.84 | -17.36 | -224.28 | -23.99 | 7.56 | -- | -770.59 | -256.64 | 1.36 | -24.02 | 0.6531 | -- | 119.69 | -34.25 | -221.68 | -- | -- | -- |
| Xtant Medical Holdings Inc | 91.30m | 660.00k | 115.89m | 207.00 | -- | 2.26 | 30.23 | 1.27 | -0.0042 | -0.0042 | 0.755 | 0.3945 | 1.19 | 1.32 | 5.78 | 441,072.50 | 0.8636 | -10.38 | 1.15 | -14.68 | 60.75 | 61.08 | 0.7229 | -8.66 | 1.22 | -4.02 | 0.2997 | -- | 57.50 | 4.81 | 107.78 | -- | 18.47 | -- |
| Outset Medical Inc | 130.38m | -172.80m | 131.84m | 480.00 | -- | 1.04 | -- | 1.01 | -3.49 | -3.49 | 2.64 | 2.44 | 0.3652 | 2.01 | 4.27 | 271,616.70 | -48.41 | -41.40 | -56.97 | -47.29 | 22.24 | 5.71 | -132.54 | -159.05 | 4.37 | -67.80 | 0.5143 | -- | 13.00 | 130.43 | -6.04 | -- | 14.27 | -- |
| Delcath Systems Inc | 2.07m | -47.68m | 138.64m | 76.00 | -- | 7.86 | -- | 67.14 | -2.98 | -2.98 | 0.1273 | 0.6931 | 0.0731 | 0.2387 | 6.80 | 27,171.05 | -168.85 | -116.57 | -377.02 | -243.21 | 69.25 | 71.02 | -2,308.86 | -1,235.37 | 2.06 | -26.53 | 0.3915 | -- | -24.05 | -9.53 | -30.60 | -- | -5.26 | -- |
| Electromed Inc | 51.69m | 3.94m | 143.97m | 170.00 | 37.20 | 3.57 | 30.93 | 2.79 | 0.4498 | 0.4498 | 5.91 | 4.69 | 1.17 | 2.95 | 2.27 | 304,076.50 | 8.91 | 7.86 | 10.39 | 9.14 | 76.51 | 76.25 | 7.62 | 7.38 | 5.25 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| Clearpoint Neuro Inc | 23.96m | -22.09m | 144.01m | 107.00 | -- | 6.19 | -- | 6.01 | -0.8979 | -0.8979 | 0.9736 | 0.8589 | 0.4881 | 1.20 | 8.15 | 223,878.50 | -45.01 | -34.75 | -52.63 | -39.67 | 56.83 | 64.75 | -92.21 | -76.91 | 3.80 | -- | 0.3197 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Butterfly Network Inc | 65.90m | -133.70m | 147.15m | 225.00 | -- | 0.6672 | -- | 2.23 | -0.6507 | -0.6507 | 0.3209 | 1.06 | 0.1826 | 0.7376 | 4.69 | 292,888.90 | -37.04 | -- | -42.70 | -- | 25.58 | -- | -202.88 | -- | 3.57 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.76m | -49.12m | 160.28m | 56.00 | -- | 2.36 | -- | 58.07 | -1.49 | -1.49 | 0.0832 | 1.90 | 0.0289 | 0.8815 | 28.31 | 49,285.71 | -51.49 | -- | -61.01 | -- | 93.26 | -- | -1,779.71 | -- | 7.94 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Inogen Inc | 315.66m | -102.45m | 164.45m | 834.00 | -- | 0.8029 | -- | 0.521 | -4.42 | -4.42 | 13.62 | 8.78 | 0.8634 | 6.76 | 6.01 | 378,489.20 | -28.02 | -8.23 | -34.53 | -9.53 | 40.14 | 44.54 | -32.46 | -10.31 | 2.56 | -- | 0.00 | -- | -16.32 | -2.49 | -22.30 | -- | 26.34 | -- |
| InfuSystem Holdings Inc | 125.79m | 872.00k | 167.35m | 499.00 | 198.59 | 3.19 | 12.46 | 1.33 | 0.0396 | 0.0396 | 5.86 | 2.47 | 1.24 | 11.17 | 6.85 | 252,074.10 | 0.8621 | 4.60 | 1.01 | 5.69 | 50.17 | 56.43 | 0.6933 | 4.07 | 1.54 | 1.88 | 0.3575 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Semler Scientific Inc | 68.18m | 20.58m | 187.17m | 92.00 | 10.13 | 2.55 | 8.84 | 2.75 | 2.63 | 2.63 | 8.71 | 10.43 | 0.9688 | 15.28 | 13.62 | 741,130.40 | 29.25 | 38.83 | 32.24 | 44.41 | 89.76 | 90.22 | 30.19 | 32.58 | 10.56 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Akoya Biosciences Inc | 96.63m | -63.32m | 187.23m | 330.00 | -- | 3.48 | -- | 1.94 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Stereotaxis Inc | 26.77m | -22.06m | 195.47m | 122.00 | -- | 11.79 | -- | 7.30 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Accuray Inc | 447.48m | -14.55m | 218.17m | 1.02k | -- | 4.58 | -- | 0.4876 | -0.1496 | -0.1496 | 4.62 | 0.4806 | 0.9469 | 1.90 | 5.37 | 436,994.20 | -3.08 | -1.45 | -5.28 | -2.48 | 33.97 | 37.86 | -3.25 | -1.62 | 0.8406 | 0.3262 | 0.7857 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
Data as of Apr 25 2024. Currency figures normalised to Inogen Inc's reporting currency: US Dollar USD
46.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Camber Capital Management LPas of 31 Dec 2023 | 2.00m | 8.57% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 1.68m | 7.19% |
| Brown Capital Management LLCas of 31 Dec 2023 | 1.56m | 6.69% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.34m | 5.74% |
| Columbia Management Investment Advisers LLCas of 31 Dec 2023 | 959.56k | 4.11% |
| Weatherbie Capital LLCas of 31 Dec 2023 | 762.54k | 3.27% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 755.83k | 3.24% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 612.30k | 2.63% |
| Meros Investment Management L.P.as of 31 Dec 2023 | 589.63k | 2.53% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 552.80k | 2.37% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
